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Summary
We describe genetic analysis of a large pedigree with an
X-linked syndrome of polyendocrinopathy, immune dys-
function, and diarrhea (XPID), which frequently results
in death during infancy or childhood. Linkage analysis
mapped the XPID gene to a 17-cM interval defined by
markers DXS8083 and DXS8107 on the X chromo-
some, at Xp11.23-Xq13.3. The maximum LOD score
was 3.99 (recombination fraction0) at DXS1235. Be-
cause this interval also harbors the gene for Wiskott-
Aldrich syndrome (WAS), we investigated mutations
in the WASP gene, as the molecular basis of XPID.
Northern blot analysis detected the same relative
amount and the same-sized WASP message in patients
with XPID and in a control. Analysis of theWASP cod-
ing sequence, an alternate promoter, and an untranslated
upstream first exon was carried out, and no mutations
were found in patients with XPID. A CrT transition
within the alternate translation start site cosegregated
with the XPID phenotype in this family; however, the
same transition site was detected in a normal control
male. We conclude that XPID maps to Xp11.23-Xq13.3
and that mutations of WASP are not associated with
XPID.
Introduction
In 1982, Powell et al. described an X-linked immuno-
deficiency syndrome associated with autoimmune enter-
opathy, polyendocrinopathy, atopic dermatitis, and fatal
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infections. T-cell activation was demonstrated by HLA-
DR expression (i.e., circulating lymphocytes and CD8
T cells infiltrating the gut) without abnormalities of
CD25, TCR alpha/beta, or TCR gamma/delta expres-
sion (Shigeoka et al. 1993). The clinical characteristics
of affected males in this pedigree included eczema, re-
current infections, and autoimmune manifestations.
Some of these features are shared with Wiskott-Aldrich
syndrome (WAS) (OMIM 301000) (Perry et al. 1980;
Sullivan et al. 1994; Ochs 1998), an X-linked disorder
with thrombocytopenia, small platelets, eczema, and
immunodeficiency. However, this syndrome, which we
designate as “X-linked polyendocrinopathy, immune
dysfunction, and diarrhea” (XPID), is clinically differ-
entiated from WAS by a lack of platelet defects and may
represent a T-cell–activation syndrome. The character-
istics of the two disorders are listed in table 1.
Mutations in the WAS gene (WASP) are associated
with WAS (Derry et al. 1994; summarized by Zhu et al.
1997; reviewed by Nonoyama 1998). Mutations in
WASP have also been found in patients with X-linked
thrombocytopenia (XLT) (MIM 313900), yet these mu-
tations are located at sites different from those described
in patients with WAS (Villa et al. 1995; Zhu et al. 1995;
De Saint Basile et al. 1996). Therefore, XLT and WAS
are allelic disorders resulting frommutations in the same
gene, with XLT having a milder phenotype and com-
monly resulting from WASP missense mutations within
the first three exons (Zhu et al. 1997). The locus for
WAS and XLT maps to Xp11.22-Xp11.23. After initial
isolation of WASP by Derry et al. (1994), Hagemann
and Kwan (1999) characterized its primary promoter
and isolated a secondary upstream promoter with an
associated untranslated exon. Since some features of
WAS and XPID are shared, we hypothesized that XPID
might map to Xp11.22-Xp11.23 and might result from
mutations in WASP, despite the fact that XPID does not
share with WAS the common feature of thrombocyto-
penia or small platelets.
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Table 1
Clinical Features of WAS versus Those of
XPID
Clinical Feature XPID WAS
Abnormal bleeding Yes Yes
Autoimmune manifestations Yes Yes
B-cell involvement No Yes
Diarrhea Yes Yes
Eczema Yes Yes
Recurrent infections Yes Yes
Small platelets No Yes
Thrombocytopenia No Yes
T-cell activation Yes No
Subjects and Methods
Description of Pedigree
We studied a five-generation Mormon pedigree
(K1768; fig. 1) of northern-European ancestry (Powell
et al. 1982). No consanguinity was present. The appar-
ent mode of inheritance was X-linked recessive with a
history of 20 affected males, 18 of whom had died of
severe infections at age 4 years. Of the remaining two
patients, one died at age 30 years, the other at age 8
years. Under a protocol of informed consent (University
of Utah Medical Center), 15–20 cc of blood was ob-
tained by venipuncture, for isolation of DNA and es-
tablishment of permanent cell lines.
Genetic Analysis
Two-point LOD scores were calculated between poly-
morphic markers and the XPID locus, by means of the
computer program LINKAGE (version 5.1) of Lathrop
et al. (1985). LOD scores (Z) were calculated under a
model of X-linked recessive inheritance. Penetrance was
taken as 1.0 for hemizygous males. The frequency of the
mutant allele was taken as .0001. For multipoint linkage
analysis, the location of the XPID gene was tested
against a fixed map of 13 markers (DXS337, DXS8083,
DXS426, DXS6941, DXS1126, DXS1039, DXS255,
DXS1204, DXS1199, DXS7132, DXS1235, DXS8107,
and DXS441), and genetic distances were taken from
Ge´ne´thon.
Reverse Transcription (RT)-PCR Primers for WAS cDNA
Synthesis
Several RT-PCR primer pairs were designed for use
withWASP (Derry et al. 1994). Pairs that gave successful
amplification are shown in table 2.
RNA Extraction and Northern Blot Analysis
Total RNA was extracted from Epstein-Barr vi-
rus–transformed B lymphocytes derived from two pa-
tients (fig. 1) and from an unrelated control, by means
of Tri Reagent (Molecular Research Center). Polyaden-
ylated RNA was isolated, by use of a column of oligo
(dT) cellulose (Stratagene), from total RNA. Polyaden-
ylated RNA (2 mg) was denatured with glyoxal (12 mM
Tris-acetate pH 7.0, 0.3 mM EDTA, 1 M glyoxal) at
50C for 30 min, size fractionated on a 1% agarose gel,
blotted onto a nylon membrane, UV cross-linked, and
hybridized at 60C overnight with 32P-labeled probe. The
probe used was a PCR product obtained with primers
5.16 (5′-GGT TTT TTCATT TCC TGT TC-3′) and 5.17
(5′-CTT GAA GCT ATG GAC ACA TAT G-3′) (Derry
et al. 1994), which amplify WASP exons 1 and 2 and
intron 1 (GenBank accession number AF115549). To
control for amounts of RNA loaded, levels of WASP
message were determined by quantitative methods
(PhosphorImager; Molecular Dynamics) and were ex-
pressed as a ratio with respect to b-actin–gene RNA
level.
DNA Sequencing
Mutation-detection analysis of WASP was done by
direct sequencing.WASPwas amplified in two segments.
A proximal section was amplified from genomic DNA,
and a distal segment was amplified from mRNA. Exons
1 and 2 (including intron 1) were amplified from patient
and control genomic DNA, with the primer pair 5.16
and 5.17 mentioned earlier (Derry et al. 1994). For ex-
ons 3–12, cDNA was synthesized from total RNA, with
viral reverse transcriptase followed by amplification by
PCR (RNA PCR kit; PE Biosystems). For 35 cycles of
PCR, the cycling parameters were 94C for 1 min, 60C
for 1 min, and 72C for 1 min. Several pairs of RT-PCR
primers were designed to amplify the cDNA sequence
of WAS (Derry et al. 1994) and are shown in table 2.
Amplified products were purified by use of Wizard PCR
preps (Promega). DNA sequencing was performed with
an ABI373A sequencer by use of the method of dideoxy
sequencing by 35S-dATP incorporation. Sequences were
analyzed by means of the Sequence Analysis software
package (Genetics Computer Group).
Primers WAS-F (5′-ATT GCC AGC TCG TGT GCG
GG-3′) and WAS-R (5′-CCT CAG CCA CCA CCA ACT
C-3′) were designed to encompass the WASP alternate
promoter and untranslated exon (Hagemann and Kwan
1999) (GenBank accession number AF115548). Se-
quencing was performed in both directions, by the
method of cycle sequencing by means of [g-33P]-dATP
primer end labeling, according to the manufacturer’s
specifications (Epicentre Technologies). Thermal cycling
was performed on an MJ Researcher PTC-100, with the
following conditions: 1 cycle at 95C for 5 min and 30
cycles at 95C for 30 s and at 70C for 1 min. Labeled
samples were resolved by electrophoresis through 6%
Bennett et al.: XPID Gene Maps to Xp11.23-Xq13.3 463
Table 2
RT-PCR Primers for WASP cDNA Synthesis
Primera Sequence
Product
Size
(bp)
273-F 5′-AGA AGT CCT ACT TCA TCC GCC-3′
846-R 5′-AAC AGA CTC CGC AGA TCT GG-3′ 574
653-F 5′-ATC ACG AGT TCA CGA TAC CG-3′
1469-R 5′-TGC TTC TCT TCT GCA TCA CG-3′ 817
1355-F 5′-GGA ATT CAG CTG AAC AAG ACC-3′
1692-R 5′-GGC AGG GAT AAC AGC ATT-3′ 338
a Numbers indicate the positions of the first 5′ nucleotides of the
primers; “F” and “R” denote forward and reverse orientation, re-
spectively. Every two lines constitute a primer pair.
Figure 1 K1768, a five-generation pedigree segregating an X-linked gene for XPID. Two affected males used for northern blot analysis
are indicated by asterisks (*). Haplotypes for markers within the X-chromosome bands Xp11.23–Xq13.3 are shown. A crossover distal to
marker DXS8083 in individual II-5 defines a proximal flanking marker for XPID. A second recombination seen in the same individual (II-5)
and in II-7 occurred distal to DXS1275, defining DXS8107 as the distal flanking marker for the XPID gene region.
polyacrylamide gels. Autoradiography was performed
for 24–48 h.
RFLP Analysis of the WASP Alternate Promoter
A 474-bp amplification fragment containing the
WASP alternate promoter and untranslated first exon
was generated with the primer pair WAS-F and WAS-
R. The 25-ml amplification reaction contained ∼75 ng
genomic DNA, 10 pmol each primer, 1# Bioline buffer
(Bioline), 0.875 U Biolase DNA polymerase (Bioline),
200 mM each dNTP, and 15% glycerol. The thermal
profile was 1 cycle at 94C for 3 min; 31 cycles at 94C
for 30 s, 66C for 55 s, and 72C for 1 min; and a final
extension cycle at 72C for 5 min.
PCR gel-extraction purifications were performed with
QIAquick gel extraction–purification columns, accord-
ing to the manufacturer’s specifications (Qiagen), and
were eluted into 40 ml of 10 mM Tris Cl, pH 8.5. Di-
gestion reactions consisted of ∼500 ng of the DNA frag-
ment discussed above, 5 UNsp I (NE Biolabs), 2 ml 10#
digestion buffer, and H2O double-distilled to 20 ml, in-
cubated for 3 h prior to heat denaturation at 65C for
20 min. Resulting fragments were resolved on 2% aga-
rose gels and were visualized under UV light after eth-
idium bromide staining.
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Table 3
LOD Scores at Various Recombination Fractions, for Markers on the X Chromosome, in Pedigree
K1768
MARKER
LOD SCORE AT RECOMBINATION FRACTION OF
MAXIMUM
RECOMBINATION
FRACTION
MAXIMUM
LOD
SCORE.0 .01 .05 .1 .2 .3 .4
DXS337  2.06 2.53 2.54 2.20 1.64 .91 .08 2.56
DXS8083  1.00 1.53 1.61 1.43 1.05 .54 .11 1.65
DXS426 3.35 3.30 3.11 2.85 2.28 1.62 .86 .00 3.35
DXS6941 1.62 1.60 1.52 1.41 1.15 .84 .46 .00 1.62
DXS1126 1.81 1.78 1.65 1.49 1.13 .75 .37 .00 1.81
DXS1039 1.46 1.44 1.35 1.23 .96 .67 .33 .00 1.46
DXS255 3.81 3.75 3.49 3.15 2.41 1.59 .74 .00 3.81
DXS1204 3.34 3.28 3.05 2.74 2.07 1.34 .64 .00 3.34
DXS1199 2.73 2.70 2.55 2.35 1.86 1.27 .59 .00 2.73
DXS7132 1.81 1.78 1.65 1.49 1.13 .75 .37 .00 1.81
DXS1235 3.99 3.92 3.64 3.28 2.50 1.65 .76 .00 3.99
DXS8107  .93 1.48 1.58 1.44 1.10 .62 .10 1.58
DXS441  -1.55 .26 .19 .47 .46 .29 .24 .49
Results
Linkage Analysis
Two-point disease-to-marker linkage analysis, with
markers spanning a 50-cM interval of the X chromo-
some, detected linkage to Xp11.23-Xq13.3 (fig. 1). A
LOD score of 3.35 with no recombination for marker
DXS426 established linkage of XPID to this region. Fur-
ther analysis with 12 additional markers in Xp11.23-
Xq13.3 revealed several markers showing significant
LOD scores with XPID (table 3). Results for multipoint
linkage analysis for all 13 markers analyzed are shown
in figure 2.
The estimated genetic distance (17 cM) of the can-
didate interval of XPID is shown in figure 3. A crossover
occurring between markers DXS8083 and DXS426 (in-
dividual II-5) defines the proximal boundary of theXPID
interval (figs. 1 and 3). A second crossover, detected in
the same individual (II-5) and in individual II-7 and
located distal to marker DXS1275 and proximal to
DXS8107, defines the distal boundary of the XPID re-
gion (figs. 1 and 3).
Northern Blot Analysis
A transcript of 2.1 kb was detected in lymphoblastoid
cell lines from two patients with XPID and from a con-
trol (fig. 4). In addition, when the amount of WASP
mRNA was expressed as a ratio to b-actin message, a
ratio of ∼0.1 was obtained for both patients and the
control cell line. These observations suggest that, in lym-
phoblasts, no grossly detectable abnormalities such as
deletions or duplications are present in the WASP mes-
sage for XPID patients and that the WASP message is
present at the same level as that found in a control cell
line.
DNA Sequence Analysis
DNA sequence analysis for the WASP coding region
was performed in two XPID patients and was compared
with the normal sequence (Derry et al. 1994). Identical
sequences were obtained in the two patients with XPID
and in the control.
DNA sequence analysis for the untranslated, alter-
nately spliced first exon, including 22 bp of putative
intron 1 and 263 bp of sequence upstream of the putative
alternate transcription start site, was performed in two
patients with XPID and a control and was compared
with that of normal persons (Hagemann and Kwan
1999). Bidirectional sequencing for each of the two sam-
ples from affected males detected a CrT transition 7 bp
distal to theWASP alternate translation start site (WASP
7 bp). This transition generates a single recognition
site (RCATG/Y) for NspI.
A 474-bp WASP fragment containing the alternate
promoter and untranslated first exon was amplified and
digested with NspI. When the NspI site is present, the
restriction digest results in two fragments, of 287 bp and
187 bp (fig. 5). Samples from 24 family members of
pedigree K1768 were analyzed for the presence of the
NspI site. The NspI site showed complete cosegregation
with XPID. DNA from 128 unrelated persons was tested
for the presence of theNspI site. TheNspI site was found
in 1 of 214 X chromosomes (a normal male), which
suggests that it is a rare single-nucleotide polymorphism
and not causal for XPID.
Discussion
We mapped the gene for XPID to a 17-cM interval
defined by the markers DXS8083 and DXS8107 on the
X chromosome (Xp11.23-Xq13.3). The pedigree with
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Figure 2 Multilocus analysis, with the XPID gene against fixed genetic map of linked markers (Ge´ne´thon). The highest probability for
location of XPID is in the region DXS426–DXS1235.
XPID described in this report has clinical features that
overlap with those ofWAS, and the locus for XPIDmaps
to the same region as does the locus for WAS. We
thought it essential to examine this gene as a possible
candidate for XPID, particularly in light of the recent
identification of the alternate transcript for which true
temporal and spatial expression is not well understood.
The WASP protein has a complex structure with
several distinct functional domains and is putatively
involved in the regulation of actin polymerization in
hematopoietic cells (Hagemann and Kwan 1999), inter-
acting with several proteins involved in the regulation
of signal transduction and cytoskeletal organization (re-
viewed by Kirchhausen 1998).WASP mutations leading
to WAS generally lead to a nonfunctional protein and
include frameshifts, splice mutations, nonsense muta-
tions, and microdeletions. Conversely,WASP mutations
leading to XLT, a milder disorder known to be allelic to
WAS, are often missense mutations found in exons 1–3
and inhibit less important functions (Zhu et al. 1997).
We hypothesized that a particular subset of WASP mu-
tations might also lead to XPID. However, in addition
to the identification of a correct in-frame coding se-
quence and correct alternate promoter sequence for
WASP, we also found the same-sized and relative
amounts of WASP transcript in patients with XPID and
in a normal control. These observations suggest that
XPID and WAS are unlikely to be allelic disorders and
implicate the existence of another gene, within this re-
gion of the X chromosome, related to immune function.
A CrT transition (WASP 7 bp) identified in this
pedigree with XPID predicts the generation of an ATG
start codon leading to a frameshift mutation. We ex-
plored the possibility that this CrT transition could re-
sult in XPID. However, the same transition was found
in a normal control male, which suggests that it is not
causal for XPID.
In addition to the lack of platelet abnormalities, XPID
is clinically distinct from WAS immunologically in that
serum IgM levels are not decreased, isohemagglutinin
titers are normal, and there is no elevation of TCR
gamma/delta on circulating T cells (Shigeoka et al.
1993). Furthermore, as was not the case for WAS, fe-
males heterozygous for XPID show no apparent clonal
selection against cells carrying the mutant gene on the
active X chromosome (Shigeoka et al. 1993).
Apart from WASP, the XPID candidate region
(DXS8083–DXS8107) is characterized by several ex-
pressed-sequence tags, many of which have no signifi-
cant homology to transcripts with known functions. An
X-linked combined immunodeficiency disorder has been
described in which abnormalities are detected in the
number and function of T lymphocytes and in the for-
mation of specific IgG antibodies (Brooks et al. 1990),
yet this syndrome results from defects of the IL2RG gene
(Tassara et al. 1995). The IL2RG gene is excluded as a
candidate for XPID, since it maps to a radiation-hybrid
bin defined by the markers DXS983–DXS995, distal to
the XPID flanking marker DXS8107 (GeneMap’99). Al-
though no other characterized genes in this interval are
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Figure 3 Genetic localization of the XPID locus to Xp11.23–Xq13.3. The horizontal bar indicates the XPID candidate interval at ∼17
cM averaged over the three genetic maps of CEPH (Fondation Jean Dausset/CEPH), Ge´ne´thon, and the Center for Medical Genetics, Marshfield
Medical Research Foundation. The relative location of a 1.1-Mb sequence-ready cosmid contig (Schindelhauer et al. 1996) is indicated at
markers DXS6941–DXS1039, a region also harboring WASP.
Figure 4 Northern blot analysis of WASP in XPID and control
RNA. Lanes 1 and 2 contain RNA from B-lymphoblastoid cell lines
derived from XPID patients; lane 3 contains RNA control. The probe
used was a PCR product generated by amplification of normal genomic
DNA with primers 5.16 and 5.17 spanning exons 1 and 2 of WASP.
A control hybridization with b-actin cDNA is also shown (bottom).
For autoradiograms, the exposure time for the WASP message was 7
d; for the b-actin control, it was overnight. The ratio of hybridization
signals for the WASP message (2.1 kb) versus the b-actin message is
∼0.1, for both patients with XPID and for a control cell line.
obvious functional candidates for XPID, this interval
may harbor the human homologue of the mouse scurfy
gene. In 1990, it was suggested that a mouse mutant
known as “scurfy” may be a model of human WAS
(Lyon et al. 1990). Interestingly, the scurfy mutation (sf)
maps near the mouse homologue of WASP (Wasp) on
the X chromosome (Derry et al. 1995). Thrombocyto-
penia, eczema, diarrhea, and immune dysfunction are
seen in sf hemizygotes (Lyon et al. 1990), raising the
possibility that the human homologue for sf is an at-
tractive positional and functional candidate gene for
XPID.
Further refinement of the XPID candidate region may
be required before a positional-cloning approach to gene
isolation is feasible. This will involve the identification
of additional families with XPID. Levy-Lahad et al.
(1993) documented a family in which twomaternal half-
brothers had polyendocrinopathy, fatal infection, enter-
opathy, and thrombocytopenia. Polyendocrinopathy,
including diabetes mellitus, enteropathy, and fatal in-
fection, are shared features in both of Levy-Lahad et
al.’s patients and in XPID, although the presence of
thrombocytopenia suggests that the former syndrome
may actually be a variant of classical WAS. Moreover,
there are several reports in which infant males had in-
tractable diarrhea with or without diabetes mellitus and
renal disease (Ellis et al. 1982; Mitton et al. 1989; Seid-
man et al. 1990; Colletti et al. 1991). Congenital hy-
pothyroidism and diabetes mellitus were present in one
of these infants (Ellis et al. 1982), and an autoimmune
mechanism was suggested in the pathogenesis (Ellis et
al. 1982; Mitton et al. 1989; Seidman et al. 1990; Col-
letti et al. 1991).
In conclusion, XPID represents a distinct clinical dis-
order among the forms of X-linked immunodeficiency
syndromes. We have mapped the gene for XPID to a 17-
cM interval defined by the markers DXS8083 and
DXS441 on chromosome Xp11.23-Xq13.3 and have ex-
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Figure 5 NspI site analysis of the WASP alternate promoter
fragment. Lane 1; 700 ng 100 bp marker (Gibco BRL); lanes 1–3, 5,
9, and 12 homozygous Nsp I; lanes 4 and 8 hemizygous Nsp I;
and lanes 6, 7, 10, and 11 heterozygousNsp I/Nsp I carrier females
within this XPID pedigree.
cluded mutations in the promoter and coding regions of
WASP as the molecular basis of this disorder. These find-
ings suggest the existence, within this region of the
X chromosome, of another gene influencing immune
function.
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